Oxytocin and uterine activity

Frontiers of Hormone Research

Volumn 27, Issue , 2001, Pages 57-65

  Zingg, Hans H ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; OXYTOCIN; OXYTOCIN RECEPTOR; PROGESTERONE;

ANIMAL; FEMALE; HUMAN; LABOR; PHYSIOLOGY; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION; UTERUS; UTERUS CONTRACTION;

ANIMALS; ESTRADIOL; FEMALE; HUMANS; LABOR, OBSTETRIC; OXYTOCIN; PREGNANCY; PROGESTERONE; RECEPTORS, OXYTOCIN; SIGNAL TRANSDUCTION; UTERINE CONTRACTION; UTERUS;

EID: 0035222840     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061041     Document Type: Article

References (55)

1. The Antocin PTL096 Study Group, Sibai BM, Romero R, Sanchez-Ramos L, et al: A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (antocin) in the treatment of preterm labor. Am J Obstet Gynecol 1997;176:S2.
2. The Antocin PTL098 Study Group, Sanchez-Ramos L, Valenzuela M, Romero R, et al: A doubleblind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor. Am J Obstet Gynecol 1997;176:S30.
3. Nathanielsz PW, Honnebier BM, Mecenas C, et al: Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturnal myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation. Biol Reprod 1997;57:320-324.
4. Renfree MB, Parry LJ, Shaw G: Infusion with an oxytocin receptor antagonist delays parturition in a marsupial. J Reprod Fertil 1996;108:131-137.
5. Giussani DA, Jenkins SL, Mecenas CA, et al: The oxytocin antagonist atosiban prevents androstenedione-induced myometrial contractions in the chronically instrumented, pregnant rhesus monkey. Endocrinology 1996;137:3302-3307.
6. Schellenberg JC: The effect of oxytocin receptor blockade on parturition in guinea pigs. J Clin Invest 1995;95:13-19.
7. Goodwin TM, Paul R, Silver H, et al: The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994;170:474-478.
8. Nishimori K, Young LJ, Guo O, et al: Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 1996;93:11699-11704.
9. Young WS III, Shepard E, Amico J, et al: Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol 1996;8:847-853.
10. Young WS III, Shepard E, DeVries AC, et al: Targeted reduction of oxytocin expression provides insights into its physiological roles. Adv Exp Med Biol 1998;449:231-240.
11. Russell JA, Leng G: Sex, parturition and motherhood without oxytocin? J Endocrinol 1998;157: 343-359.
12. Soloff MS, Alexandrova M, Fernstrom MJ: Oxytocin receptors: Triggers for parturition and lactation? Science 1979;204:1313-1315.
13. Lefebvre DL, Piersanti M, Bai XH, Chen ZQ, Lye SJ: Myometrial transcriptional regulation of the gap junction gene, connexin-43. Reprod Fertil Dev 1995;7:603-611.
14. Zingg HH: Vasopressin and oxytocin receptors. Baillières Clin Endocrinol Metab 1996;10:75-96.
15. Lefebvre DL, Giaid A, Bennett H, Lariviere R, Zingg HH: Oxytocin gene expression in rat uterus. Science 1992;256:1553-1555.
16. Chibbar R, Miller FD, Mitchell BF: Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. J Clin Invest 1993;91:185-192.
17. Lefebvre DL, Farookhi R, Giaid A, Neculcea J, Zingg HH: Uterine oxytocin gene expression. II. Induction by exogenous steroid administration. Endocrinology 1994;134:2562-2566.
18. Lefebvre DL, Farookhi R, Larcher A, Neculcea J, Zingg HH: Uterine oxytocin gene expression. I. Induction during pseudopregnancy and the estrous cycle. Endocrinology 1994;134:2556-2561.
19. Mitchell BF, Fang X, Wong S: Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition. Biol Reprod 1998;59:1321-1327.
20. Chen DC, Chan WY, Manning M: Agonist and antagonist specificities of decidual prostaglandinreleasing and myometrial uterotonic oxytocin receptors in pregnant rats. J Reprod Fertil 1994;102: 337-343.
21. 125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: A selective oxytocin receptor ligand. Eur J Pharmacol 1988;147:197-207.
22. Fuchs AR, Fuchs F, Husslein P, Soloff MS: Oxytocin receptors and human parturition: A dual role for oxytocin in the initiation of labor. Science 1984;215:1396-1398.
23. 125I-labeled oxytocin antagonist, d(CH2)5[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT. Biochem Cell Biol 1989;67:152-162.
24. Antoni F: Oxytocin receptors in rat adenohypophysis: Evidence from radioligand binding studies. Endocrinology 1986;119:2393-2395.
25. Tribollet E, Barberis C, Jard S: Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res 1988;442:105-118.
26. Tribollet E, Barberis C, Arsenijevic Y: Distribution of vasopressin and oxytocin receptors in the rat spinal cord: Sex-related differences and effect of castration in pudendal motor nuclei. Neuroscience 1997;78:499-509.
27. Tribollet E, Barberis C, Dreifuss JJ: Autoradiographic localization of vasopressin amd oxytocin binding sites in rat kidney. Kidney Int 1988;33:959-965.
28. Elands J, Resink A, De Kloet ER: Oxytocin receptors in the rat thymic gland. Eur J Pharmacol 1988;151:345-346.
29. Fuchs A-R, Behrens O, Helmer H: Oxytocin and vasopressin binding sites in human and bovine ovaries. Am J Obstet Gynecol 1990;163:1961-1967.
30. Bathgate RAD, Sernia C: Characterization and localization of oxytocin receptors in the rat testis. J Endocrinol 1994;141:343-352.
31. Gutkowska J, Jankowski M, Lambert C, et al: Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 1997;94:11704-11709.
32. Thibonnier M, Conarty DM, Preston JA, et al: Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999;140:1301-1309.
33. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H: Structure and expression of a human oxytocin receptor. Nature 1992;356:526-529.
34. Rozen F, Russo C, Banville D, Zingg HH: Structure, characterization, and expression of the rat oxytocin receptor gene. Proc Natl Acad Sci USA 1995;92:200-204.
35. Gorbulev V: Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line. Eur J Biochem 1993;215:1-7.
36. Riley PR, Flint AP, Abayasekara DR, Stewart HJ: Structure and expression of an ovine endometrial oxytocin receptor cDNA. J Mol Endocrinol 1995;15:195-202.
37. Bathgate R, Rust W, Balvers M, et al: Structure and expression of the bovine oxytocin receptor gene. DNA Cell Biol 1995;14:1037-1048.
38. Kubota Y, Kimura T, Hashimoto K, et al: Structure and expression of the mouse oxytocin receptor gene. Mol Cell Endocrinol 1996;124:25-32.
39. Barberis C, Mouillac B, Durroux T: Structural basis of vasopressin/oxytocin receptor function. J Endocrinol 1998;156: 223-229.
40. Chini B, Mouillac B, Ala Y, et al: Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J 1995;14:2176-2182.
41. Chini B, Mouillac B, Balestre MN, et al: Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett 1996;397:201-206.
42. Wheatley M, Hawtin SR, Yarwood NJ: Structure/function studies on receptors for vasopressin and oxytocin. Adv Exp Med Biol 1998;449:363-365.
43. Postina R, Kojro E, Fahrenholz F: Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem 1996;271: 31593-31601.
44. Postina R, Kojro E, Fahrenholz F: Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv Exp Med Biol 1998;449:371-385.
45. Larcher A, Neculcea J, Breton C, et al: Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology 1995; 136:5350-5356.
46. Breton C, Pechoux C, Morel G, Zingg HH: Oxytocin receptor messenger ribonucleic acid: Characterization, regulation, and cellular localization in the rat pituitary gland. Endocrinology 1995;136: 2928-2936.
47. Breton C, Zingg HH: Expression and region-specific regulation of the oxytocin receptor in rat brain. Endocrinology 1997;138:1857-1862.
48. Breton C, Neculcea J, Zingg HH: Renal oxytocin receptor messenger ribonucleic acid: Characterization and regulation during pregnancy and in response to ovarian steroid treatment. Endocrinology 1996;137:2711-2717.
49. Fuchs AR, Periyasamy S, Alexandrova M, Soloff MS: Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: Effects of ovarian steroids. Endocrinology 1983;113:742-749.
50. Soloff MS, Fernstrom MA, Periyasamy S, et al: Regulation of oxytocin receptor concentration in rat uterine explants by estrogen and progesterone. Can J Biochem Cell Biol 1983;61:625-630.
51. Grazzini E, Guillon G, Mouillac B, Zingg HH: Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998;392:509-512.
52. Ohmichi M, Koike K, Nohara A, et al: Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 1995;136:2082-2087.
53. Strakova Z, Copland JA, Lolait SJ, Soloff MS: ERK2 mediates oxytocin-stimulated PGE2 synthesis. Am J Physiol 1988;274:E634-E641.
54. Nohara A, Ohmichi M, Koike K, et al: The role of mitogen-activated protein kinase in oxytocininduced contraction of uterine smooth muscle in pregnant rat. Biochem Biophys Res Commun 1996;229:938-944.
55. Molnar M, Rigo J Jr, Romero R, Hertelendy F: Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol 1999;181:42-49.